SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 4th, 2013 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November __, 2013, between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
STRICTLY CONFIDENTIAL IntelGenx Technologies Corp. 6425 Abrams St-Laurent, QC H4S 1X9 Attn: Horst Zerbe Dear Dr. Zerbe:Placement Agent Agreement • December 4th, 2013 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between IntelGenx Technologies Corp. (the “Company”) and H.C. Wainwright & Co., LLC (“HCW”) that HCW shall serve as the exclusive US placement agent (the “Services”) for the Company, on a “best efforts” basis, in connection with the proposed offering by the Company (the “Offering”) on a registration statement on Form S-1 (the “Form S-1”) of between USD$3,000,000 and USD$6,000,000 of shares (the “Shares”) of common stock, $0.00001 par value per share, of the Company (“Common Stock”) and warrants to purchase shares of Common Stock (the “Warrants” and, collectively with Shares and shares of Common Stock underlying the Warrants, the “Securities”). The terms of the Offering and issuance of Securities in the Offering shall be mutually agreed upon by the Company and the investors (the “Investors”) at the time of the Offering and nothing herein implies that HCW would have the power or authority to bind the Company or an obligation for the
